Category Archives: News

FDA Approves Kesimpta (ofatumumab) Targeted B-cell Therapy for Patients with Relapsing Multiple Sclerosis

FDA Approves Kesimpta (ofatumumab) Targeted B-cell Therapy for Patients with Relapsing Multiple Sclerosis Print this page Basel, August 20, 2020 — Novartis today announced that the US Food and Drug Administration (FDA) has approved Kesimpta® (ofatumumab, formerly OMB157) as an injection for subcutaneous use for the treatment of relapsing forms of multiple sclerosis (RMS), to include clinically… Read More: FDA Approves Kesimpta (ofatumumab) Targeted B-cell Therapy for Patients with… »

Coronavirus antibodies tests ‘put public at risk’

Poor regulation of antibodies tests – that could indicate if someone has had coronavirus – could be putting the public at risk, doctors have warned. The Royal College of Pathologists has written to the health secretary, calling for rules to be tightened on kits sold direct to consumers. The letter warns they can “mislead the… Read More: Coronavirus antibodies tests ‘put public at risk’ »

Hormonal treatments for prostate cancer are often given late

Men with advanced prostate cancer are typically treated with drugs that cause testosterone levels to plummet. Testosterone is a hormone that fuels growing prostate tumors, so ideally this type of treatment, which is called androgen deprivation therapy (ADT), or hormonal therapy, will stall the disease in its tracks. For that to happen, ADT has to… Read More: Hormonal treatments for prostate cancer are often given late »

Jonathan Gill Says Great Companies Don’t Need Fixed Offices—Only Great People

Over the last few years, Jonathan Gill’s road to success has taken him a number of directions. And as the founder and CEO of Backtracks, an audio analysis company focused on helping podcasters measure data, he’s also used to overcoming different problems on the fly. Gill recently sat down with Men’s Health Deputy Editor Spencer… Read More: Jonathan Gill Says Great Companies Don’t Need Fixed Offices—Only Great… »